早期前列腺癌主动监测的远期转移风险
该研究回顾性分析了1990至2018年在本机构接受主动监测的低/中危前列腺癌患者1450例,中位随访77个月,7年无转移生存率为99%,仅15例发生转移,GG2、PSA速率及mpMRI PI-RADS 4-5与转移风险升高相关,7年前列腺癌特异性生存超过99%。
要点
- 主动监测的7年无转移生存率达99%,转移和癌特异性死亡罕见。
- GG2、PSA速率及mpMRI PI-RADS 4-5病灶与转移风险升高相关。
- 选择主动监测患者时应考虑上述风险因素进行咨询。
核心结论
- 主动监测可维持良好的长期预后,转移和前列腺癌特异性死亡罕见。
- GG2、PSA速率及mpMRI PI-RADS 4-5病灶与转移风险升高相关,选择患者时应予以考虑。
研究设计与样本
- 回顾性分析1990至2018年在本机构纳入主动监测的低/中危前列腺癌患者(cT1-2、PSA<20 ng/ml、活检GG1-2)。
- 共纳入1450例,中位随访77个月(IQR 49-114),按诊断GG和PSA密度分为3组。
- 主要终点为影像学或前列腺切除标本发现的转移性前列腺癌,采用Cox比例风险回归模型分析。
主要发现
- 7年无转移生存率为99%。
- 15例发生转移,中位转移时间62个月(IQR 29-104),其中69%局限于淋巴结。
- GG2患者无转移生存率低于GG1患者。
- GG2、PSA速率及mpMRI PI-RADS 4-5病灶与转移风险升高相关。
- 7年前列腺癌特异性生存率超过99%。
关键数值与推荐
- 7年无转移生存率99%,7年前列腺癌特异性生存率>99%。
- 转移发生15例,中位时间62个月(IQR 29-104),69%局限于淋巴结。
- GG2、PSA速率及mpMRI PI-RADS 4-5病灶与转移风险升高相关。
临床怎么用
- 对低/中危前列腺癌患者,主动监测可作为保留长期预后的管理选择。
- 选择主动监测患者及咨询时,应评估GG、PSA速率和mpMRI PI-RADS 4-5病灶等转移风险因素。
局限性
- 回顾性单中心研究设计。
- 转移事件数较少(15例),可能限制统计效能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We assessd the long-term outcomes from a large prospective cohort of men diagnosed with prostate cancer managed with active surveillance and determined the clinical prognostic factors that may predict the risk of metastases. MATERIALS AND METHODS: We retrospectively reviewed data of men enrolled on active surveillance at our institution between 1990 and 2018 with low or intermediate risk disease (stage cT1-2, prostate specific antigen less than 20 ng/ml, and biopsy Grade Group [GG]1-2). Patients were classified into 3 groups by diagnostic GG and prostate specific antigen density. Primary outcome was metastatic prostate cancer detected on imaging or at prostatectomy. In addition, upgrade at surveillance biopsy, active treatment, and overall and prostate cancer specific survival outcomes were assessed. Cox proportional hazards regression models were used. RESULTS: A total of 1,450 men met the inclusion criteria. Median followup was 77 months (IQR 49-114). The 7-year metastasis-free survival rate was 99%. Metastases developed in 15 men at a median of 62 months (IQR 29-104), of which 69% were confined to lymph nodes. Men with GG2 had a lower metastasis-free survival rate compared to those with GG1 disease. GG2, prostate specific antigen velocity and PI-RADS® 4-5 lesions on multiparametric magnetic resonance imaging were associated with a higher risk of metastases. The 7-year prostate cancer specific survival was greater than 99%. CONCLUSIONS: Active surveillance seems to preserve favorable long-term prognosis, as metastases and prostate cancer specific death are rare. However, the higher risk of metastases associated with higher Gleason grade, prostate specific antigen velocity, and characteristics on multiparametric magnetic resonance imaging should be considered when selecting and counseling patients for active surveillance.
引用
- Maggi M, Cowan JE, Fasulo V, et al. The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer. J Urol. 2020. PMID: 33157570. doi:10.1097/JU.0000000000001313
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。